Showing 801-810 of 3255 results for "".
How to Humanize Medicine
https://practicaldermatology.com/conferences/noah-worcester/how-to-humanize-medicine/57074/Michael Greenberg, MD, discusses his presentation, “What I Would Teach Residents – Humanizing Medicine,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.Behavioral Interview Considerations
https://practicaldermatology.com/conferences/noah-worcester/behavioral-interview-considerations/57077/Robert Brodell, MD, discusses his presentation, “Helping Students 'Ace' their Behavioral Interview for Medical School or Residency,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.Finding the Right Medication for the Right Patient with Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37180/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, explains how to select the optimal therapeutic option for each different atopic dermatitis patient.The Role of Systemic Steroids in Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37139/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, discusses the role of systemic steroids in treating atopic dermatitis.Strategies for Treating Patients on GLP-1 Receptor Agonists and More
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/strategies-for-treating-patients-on-glp-1-receptor-agonists-and-more/54646/Suneel Chilukuri, MD, discusses key takeaways from the “What’s My Treatment? How to Combine Dermal Filler, Neuromodulators, Laser/Light/RF Devices/Microneedling and Cosmeceuticals Symposium” workshop at Maui Derm Hawaii 2026.Evaluating Roflumilast for Seborrheic Dermatitis
https://practicaldermatology.com/series/skin-minute/evaluating-roflumilast-for-seborrheic-dermatitis/54610/Practical Dermatology Editorial Board member Raj Chovatiya, MD, PhD, MSCI, discusses results from the Phase 3 STRATUM trial studying the efficacy of roflumilast for the treatment of seborrheic dermatitis in patients with diverse skin types.Practical Strategies for Improving Patient Adherence with Topical Regimens
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/practical-strategies-for-improving-patient-adherence-with-topical-regimens/39707/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, describes tactics involving topical therapeutics to improve patient adherence with atopic dermatitis.Growing into the Role of a KOL
https://practicaldermatology.com/programs/practical-dermatology/tbd/39738/Michael H. Gold, MD, founder/medical director of Gold Skin Care Center, shares his path and strategies becoming a key opinion leader in dermatology. This video was recorded at the Science of Skin Summit in Austin, TX.Seborrheic Dermatitis Approaches and Stopping Biologic Treatment for Atopic Dermatitis
https://practicaldermatology.com/conferences/scale-2025/seborrheic-dermatitis-approaches-and-stopping-biologic-treatment-for-atopic-dermatitis/35896/Naiem T. Issa, MD, PhD, talks at Music City SCALE 2025 about how to approach seborrheic dermatitis, as well as what happens to atopic dermatitis patients after ending biologic treatments.DermWire TV Extra: Spironolactone on TikTok
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-spironolactone-on-tiktok/33016/George Washington University clinical instructor of Dermatology Emily Murphy, MD, and medical student Savanna Vidal discuss their research regarding the quality and reliability of information on TikTok about spironolactone for acne treatment.